TY  - RPRT
TI  - The MEK1/2 pathway as a therapeutic target in high-grade serous ovarian carcinoma
AU  - Chesnokov, M.
AU  - Khan, I.
AU  - Park, Y.
AU  - Ezel, J.
AU  - Mehta, G.
AU  - Yousif, A.
AU  - Hong, L.
AU  - Buckanovich, R. J.
AU  - Chefetz Menaker, I.
PY  - 2019
DO  - 10.1101/772061
UR  - https://www.biorxiv.org/content/10.1101/772061v1
ID  - 10.1101/772061
ER  -